Dr. Vipin Yadav

As the Outreach In-Charge at ECH Incubation Centre, I play a pivotal role in supporting and nurturing startups by coordinating with them on a daily basis. My responsibilities include mentoring entrepreneurs, connecting them with experts, and providing essential networking opportunities to foster their growth. I actively facilitate collaborations, partnerships, and knowledge-sharing sessions, ensuring startups have access to the resources they need to succeed. Through my role, I aim to create a thriving entrepreneurial ecosystem that drives innovation and sustainability.

• American Society of Microbiology (ASM)
• IndoGlobal Health Care Research Foundation

• CSIR–JRF (Life Sciences), 06/01/10
• CSIR-LS (Life Science), 12/01/09
• GATE-2009, Qualified
• M.Sc. Environmental Science, JNU, Selected
• M.Sc. Life Science, JNU, Selected
• JNU All India M.Sc. Biotech Entrance, Toplisted

• Innovator’s Summit 2023, 01/31/24 - 02/05/24, Jawahar Kala Kendra, Jaipur
• Sustainopreneurship- A Small Step Towards Greener Planet, 12/03/21 - 12/04/21, University of Rajasthan, Jaipur
• National Seminar on 'Chemistry as Central Science: Recent Trends and Future Challenges', 09/14/19, Mewar University, Chittorgarh, Rajasthan
• BioEpoch 2017: An Annual Scientific Symposium, 03/23/17 - 03/24/17, Jawaharlal Nehru University
• International Symposium on 'Novel Strategies for Targeted Prevention and treatment of Cancer', 12/19/08 - 12/20/08, Jawaharlal Nehru University, India
• International Symposium on 'Small Meeting on Yeast Transport and Energetics (SMYTE)', 09/23/10 - 09/27/10, The Heritage Village, Manesar, Gurgaon

• Production and Characterization of a Polyclonal Antibody against Bur6a subunit of NC2 complex involved in Candida albicans Drug resistances, European Journal of Pharmaceutical and Medical Research, 4.16, 2394-3211, 2016, 3, 10, 157-162
• Transcriptional Regulation of CDR1, a major efflux pump involved in multidrug resistance in Candida albicans, Int. J. Curr. Microbiol. App. Sci, 2.93, 2014, 3, 6, 399-407
• Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans, Eukaryotic Cell, 3.58, 2011, 10, 10, 1357-66, 2011-08-19
• Cellular lipidome remodeling in acquired fluconazole resistance in selected sequential clinical isolates of Candida albicans isolated from a single HIV-infected patient over a period of two years of drug therapy, Plos One, 3.24, 2012-06-27, 10.1371/journal.pone.0039812

• Ph.D., 2018, Prof. P.J. John, Transcriptional Regulation of Multidrug Resistance in Human Pathogenic Fungi Candida albicans
• 2009-2010, Prof. Rajendra Prasad, Promoter analysis of ERG3 and ERG11 in response to iron deprivation in Candida albicans